Tessic Health alternatives for a changing health-brand business

How should you build this shortlist?

An alternative search is most useful when it starts with a concrete mismatch: a new brand, a required integration, a support need or a commercial term. Write that mismatch in one sentence. Then identify the systems and patient relationships you want to preserve. This avoids replacing an entire operating environment to solve a smaller problem that could be addressed through a different configuration or agreement.

The options below include managed platforms, modular clinical services and a software route. They are not identical substitutes. Use the white-label platform guide to map the work each model leaves with you. Compare proposals against the requirement that prompted the search, and keep optional future features separate from capabilities needed to run the business now.

Which alternative fits which buying question?

The following are evaluation routes, not claims that one vendor is universally best. Public-source review date: October 22, 2026. Confirm the current written scope before contracting.

When should TEHR be the first alternative you evaluate?

TEHR is relevant when you want brand-facing software and administrative operations coordinated with independent clinical services. Its flat subscription and flat transaction fee carry 0% revenue share; contact TEHR for a scoped quote and confirm the exact service and support boundaries. The comparison should focus on the work your organization needs handled, not a claim that this fee structure is unique.

TEHR’s operators built DudeMeds, Peptiders, TellyMeds and FansMeds and migrated thousands of their own patients. Ask them to show how the platform handles your current workflow and the specific requirement driving the switch. The strength to evaluate is operational fit; the tradeoff is that launch, migration and optional services need individual scoping rather than an assumed universal package.

When does Cuvo provide a useful managed-platform comparison?

Cuvo publishes managed plan pricing and implementation scope. It is a useful comparison when you want to keep an operated platform model but assess a different package, support arrangement or commercial structure.

The strength is a public package structure that can anchor a detailed quote. The tradeoff is that setup and tier-specific capabilities still need to match your actual requirements. Ask what a new brand, existing website or custom integration changes in the implementation plan. Do not assume a similarly named tier covers the same work as your current plan. Compare deliverables, acceptance criteria and ongoing ownership, and request a transition process for the patients and subscriptions you already serve.

When is FUSE a different implementation option?

FUSE offers self-service, guided and managed build routes. It can fit a team that wants to change how much of the initial brand configuration it owns or purchases as a service.

The strength is choice in build involvement; the tradeoff is that merchant service fees and potential third-party costs need a complete model. Resolve its inconsistent public DIY monthly figure with a written quote. Ask what happens when you add a new workflow after the initial launch and which support commitments continue. The most convenient build path is not necessarily the one that best serves your ongoing operation, so test recurring orders and exceptions as carefully as the initial storefront.

When does Lithos make sense instead of a managed storefront?

Lithos positions a practice behind the customer’s product. Evaluate it when your team wants more ownership of the application and is prepared to maintain the clinical-service connection.

The strength is retaining product control. The tradeoff is the engineering and operational work that remains outside the practice interface. Ask which staff systems you must build or retain and how they will handle incomplete encounters, patient messages and order status. A move from a managed platform to a modular architecture can be appropriate, but it should be a deliberate organizational choice. Compare retained labor and incident ownership with the platform cost rather than looking only at visit rates.

When should Beluga’s modular routes be shortlisted?

Beluga describes multiple integration paths, including direct and hosted options. It may fit if your current commerce or product layer should remain and the change is primarily in clinical infrastructure.

The strength is choosing a connection boundary that preserves existing investment. The tradeoff is coordinating the systems and partners around that boundary. Ask who supplies the storefront, portal and communication layer in the proposed route and which commercial agreements cover them. Do not assume the capabilities of one partner configuration apply to every route. The Beluga comparison is useful for separating the clinical backend from the surrounding patient experience and procurement responsibilities.

When should CareValidate be evaluated for service coverage?

CareValidate describes clinical and patient-support infrastructure. It is relevant if the reason for changing platforms is the ongoing service work rather than a missing visual customization or pricing tier.

The strength to test is coordination across patient needs, clinical handoffs and fulfillment. The tradeoff is that the exact commercial scope must be obtained directly; numerical public terms were not established in this review. Ask the team to resolve a realistic case involving more than one function and identify who owns the final outcome. A broad support promise is useful only when the coverage hours, response expectations and exclusions match the work your team is trying to remove.

When is MD Integrations a narrower clinical alternative?

MD Integrations provides API and ready-made white-label routes. It belongs on the shortlist if your organization is willing to keep commerce and operational systems elsewhere while evaluating a clinical-service connection.

The strength is choice of integration path; the tradeoff is program and service scope. Its FAQ excludes controlled-substance prescribing, so check intended care pathways before building around a broad hormone label. Ask how recurring patient communication and fulfillment information connect to your retained systems. If your current platform supplies more of the operating environment, account for that work explicitly in the new plan. A lower apparent clinical subtotal may leave additional software, staffing and coordination to procure.

When should Healthie be considered instead of a full operating bundle?

Healthie’s full web white-label offering is an Enterprise software add-on. Consider it when the organization already has clinical and operational arrangements and primarily wants a branded practice-software environment.

The strength is a software-centered approach around an existing care business. The tradeoff is that clinicians, fulfillment and other services are not established merely by buying software. Ask what the Enterprise scope covers and how it integrates with the providers and commercial systems you retain. Entry-level software prices should not be used as a complete health-brand operating budget. This is a different architecture, which can be appropriate if the team deliberately wants to own more of the surrounding operation.

How do you compare the cost of leaving with the cost of staying?

Put the current contract and each proposed replacement into the same timeline. Include remaining commitments, transition assistance, implementation work, staff training and any period when systems run in parallel. Model the requirement driving the change as a concrete deliverable: a new integration, improved support coverage or a different product boundary. Without that link, a migration can create expense without solving the original issue.

Tessic’s data-portability description is relevant to exit planning, but it does not replace a source-specific export agreement or prove an inbound migration service. Use the patient migration checklist to validate records, active care, open orders and subscriptions separately. Ask the new team to identify exceptions before committing to a full cutover. The strongest alternative is the one that resolves your documented mismatch while preserving continuity, not simply the one with the smallest first invoice.

How should a second brand affect the decision?

If expansion into another brand is driving the search, define what will be shared and what must stay separate. Consider customer identity, storefront content, staff access, commercial reporting and support routing. Ask each candidate to demonstrate that arrangement rather than only saying it supports multiple brands. A portfolio should not require staff to infer which rules apply from a logo alone. Compare the cost of the proposed configuration with the operational clarity it provides, and confirm how a later brand could be separated or transferred if the business changes. This is a concrete requirement that can justify a different plan or platform without relying on a generic promise of scale.

What is the next useful step?

Compare two or three written scopes against the operating brief you developed. Use TEHR vs Tessic Health for the direct comparison, TEHR pricing for the commercial structure and a TEHR demo to test your own workflow. The resource library includes further implementation and procurement guides.

What else should you know?